The Drug That's Reshaping the Global Economy

WeightWatchers went bankrupt. Months later, Eli Lilly became the first healthcare company in history to reach a $1 trillion valuation. Those events were connected. This isn't really the story of Ozempic, Wegovy, Mounjaro, or Zepbound. It's the story of how a single class of medicines—GLP-1 drugs—is creating the first demand shock in modern economic history delivered through a prescription. As millions of people change how much they eat, entire industries are being forced to adapt. Grocery stores are seeing smaller shopping baskets. Food manufacturers are redesigning products. Airlines are calculating lower fuel consumption. Pharmaceutical companies are investing tens of billions of dollars into manufacturing. Governments are reshaping healthcare policy. Meanwhile, investors face a different question: if demand keeps growing while prices collapse, who actually captures the value? This documentary explores the economics behind the GLP-1 revolution, why Eli Lilly overtook Novo Nordisk, how Denmark became dependent on a single pharmaceutical company, why generic competition could change everything, and what this means for the global economy over the next decade. If you're interested in economics, investing, healthcare, business, or technology, this is the story behind one of the biggest market transformations of the decade. ━━━━━━━━━━━━━━━━━━━━━━ Chapters 00:00 The Anomaly 00:50 The GLP-1 Explosion 02:00 Bigger Than Pharma 03:20 Why These Drugs Changed Everything 04:55 Winners and Losers 06:40 The Bull vs. Bear Case 09:00 Why It Matters ━━━━━━━━━━━━━━━━━━━━━━ System Atlas Mapping the systems shaping the modern world. We create premium documentaries explaining the infrastructure, markets, technology, healthcare, and economic forces transforming the global economy. Subscribe for new documentaries every week. ━━━━━━━━━━━━━━━━━━━━━━ #GLP1 #Ozempic #Economics #Wegovy #Mounjaro #Zepbound #EliLilly #NovoNordisk #WeightLoss #WeightLossDrugs #Healthcare #HealthcareEconomics #Pharmaceuticals #Pharma #Biotech #Business #BusinessDocumentary #Investing #StockMarket #Finance #MarketAnalysis #GlobalEconomy #EconomicHistory #HealthcareInnovation #Obesity #MedicalInnovation #SystemAtlas Data compiled from public sources. This documentary is intended for educational purposes only and is based on publicly available information believed to be accurate at the time of publication. It is not medical or investment advice.